Zobrazeno 1 - 10
of 126
pro vyhledávání: '"R.J Snijder"'
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 22, Iss , Pp 163-168 (2019)
Background: To improve clinical outcome, patients with inoperable and residual chronic thromboembolic pulmonary hypertension (CTEPH) can be treated with riociguat. The aim of this study is to explore long-term outcomes and to compare our ‘real worl
Externí odkaz:
https://doaj.org/article/8545e7a2776a4998a242f4789d10f3b0
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 29, Iss , Pp 100544- (2020)
Objective: The current experience with combination therapy in chronic thromboembolic pulmonary hypertension (CTEPH) is limited. We present the first survival results up to 5 years for dual combination therapy versus monotherapy in CTEPH. Methods: All
Externí odkaz:
https://doaj.org/article/25a14192859343178b4b320352b00a28
Autor:
Thomas Engstrøm, Thomas R. Keeble, Pieter-Jan Palmers, Bernard De Bruyne, Guus R. G. Brueren, Richard Good, Inge Wijnbergen, R.J. Snijder, Jacob Lønborg, Kenneth Mangion, Keith G. Oldroyd, Mohamed El Farissi, Colin Berry, Pieter J. Vlaar, Nico H.J. Pijls, Bastiaan Zwart, Koen Teeuwen, Luuk C. Otterspoor, Annemiek De Vos, Ole Fröbert, Pim A.L. Tonino, Grigoris V. Karamasis
Publikováno v:
El Farissi, M, Good, R, Engstrøm, T, Oldroyd, K G, Karamasis, G V, Vlaar, P J, Lønborg, J T, Teeuwen, K, Keeble, T R, Mangion, K, De Bruyne, B, Fröbert, O, De Vos, A, Zwart, B, Snijder, R J R, Brueren, G R G, Palmers, P J, Wijnbergen, I F, Berry, C, Tonino, P A L, Otterspoor, L C & Pijls, N H J 2021, ' Safety of Selective Intracoronary Hypothermia During Primary Percutaneous Coronary Intervention in Patients With Anterior STEMI ', JACC: Cardiovascular Interventions, vol. 14, no. 18, pp. 2047-2055 . https://doi.org/10.1016/j.jcin.2021.06.009
Objectives The aim of this study was to determine the safety of selective intracoronary hypothermia during primary percutaneous coronary intervention (PPCI) in patients with anterior ST-segment elevation myocardial infarction (STEMI). Background Sele
Autor:
H Mathijssen, M.P Huitema, A.L.M Bakker, F Smits, R.J Snijder, H.J Mager, J.C Grutters, M.C Post
Publikováno v:
European Heart Journal. 41
Background Pulmonary hypertension (PH) is a known complication of pulmonary sarcoidosis and its aetiology is unclear. The severity of PH may not correlate well with the degree of parenchymal disease; therefore other pathophysiological mechanisms have
Autor:
J. Vos, A.P.J. van Dijk, Tim Leiner, Gertjan T. Sieswerda, Mieke M. P. Driessen, M.C. Post, Folkert J. Meijboom, Robin Nijveldt, R.J. Snijder
Publikováno v:
European Heart Journal. 41
Introduction Precapillary pulmonary hypertension (pPH) causes right ventricular (RV) pressure overload inducing RV remodeling, often resulting in dysfunction and dilatation, heart failure, and ultimately death. The ability of the right ventricle to a
Autor:
M. van Leersum, D.A.F. van den Heuvel, R.J. Snijder, M.J.L. van Strijen, Jan Albert Vos, Johannes J. Mager, S. Kroon, M.C. Post
Publikováno v:
Clinical radiology. 76(5)
AIM To determine whether there are differences between idiopathic and hereditary haemorrhagic telangiectasia (HHT) associated pulmonary arteriovenous malformations (PAVMs) (HHT-PAVM) regarding clinical and radiographic characteristics, and the result
Publikováno v:
International Journal of Cardiology. Heart & Vasculature
International Journal of Cardiology: Heart & Vasculature, Vol 29, Iss, Pp 100544-(2020)
Int J Cardiol Heart Vasc
International Journal of Cardiology: Heart & Vasculature, Vol 29, Iss, Pp 100544-(2020)
Int J Cardiol Heart Vasc
Highlights • Long-term overall survival of CTEPH patients receiving PH-specific medial therapy is very reasonable. • Despite worse baseline characteristics at baseline, combination therapy showed similar survival as monotherapy. • Combination t
Autor:
Johannes J. Mager, D. A. F. van den Heuvel, Robin H. Heijmen, Esther J. Nossent, Benno J. Rensing, M.C.J. van Thor, M. A. M. Beijk, Petr Symersky, R.J. Snijder, A. Vonk Noordegraaf, Harm-Jan Bogaard, Rutger J. Lely, Lilian J. Meijboom, M.C. Post, Natalia J Braams, L. ten Klooster
Publikováno v:
Netherlands heart journal, 28(2), 81-88. Bohn Stafleu van Loghum
Netherlands Heart Journal, 28(2), 81-88. Bohn Stafleu van Loghum
Netherlands Heart Journal
van Thor, M C J, Lely, R J, Braams, N J, ten Klooster, L, Beijk, M A M, Heijmen, R H, van den Heuvel, D A F, Rensing, B J W M, Snijder, R J, Vonk Noordegraaf, A, Nossent, E J, Meijboom, L J, Symersky, P, Mager, J J, Bogaard, H J & Post, M C 2020, ' Safety and efficacy of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension in the Netherlands ', Netherlands Heart Journal, vol. 28, no. 2, pp. 81-88 . https://doi.org/10.1007/s12471-019-01352-6
Netherlands Heart Journal, 28(2), 81-88. Bohn Stafleu van Loghum
Netherlands Heart Journal
van Thor, M C J, Lely, R J, Braams, N J, ten Klooster, L, Beijk, M A M, Heijmen, R H, van den Heuvel, D A F, Rensing, B J W M, Snijder, R J, Vonk Noordegraaf, A, Nossent, E J, Meijboom, L J, Symersky, P, Mager, J J, Bogaard, H J & Post, M C 2020, ' Safety and efficacy of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension in the Netherlands ', Netherlands Heart Journal, vol. 28, no. 2, pp. 81-88 . https://doi.org/10.1007/s12471-019-01352-6
Background Balloon pulmonary angioplasty (BPA) is an emerging treatment in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and chronic thromboembolic disease (CTED). We describe the first safety and efficacy results of BPA in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf1d04bc03b3a27b6a95de1705d6692d
https://pure.amc.nl/en/publications/safety-and-efficacy-of-balloon-pulmonary-angioplasty-in-chronic-thromboembolic-pulmonary-hypertension-in-the-netherlands(7a115698-0c51-42e5-898f-7100a52f8021).html
https://pure.amc.nl/en/publications/safety-and-efficacy-of-balloon-pulmonary-angioplasty-in-chronic-thromboembolic-pulmonary-hypertension-in-the-netherlands(7a115698-0c51-42e5-898f-7100a52f8021).html
Publikováno v:
Journal of Interventional Cardiology
Journal of Interventional Cardiology, Vol 2020 (2020)
Journal of Interventional Cardiology, Vol 2020 (2020)
Purpose. The Occlutech Figulla occluder has been proven safe and effective at midterm follow-up after percutaneous atrial septal defect (ASD) closure. We describe the safety and efficacy at long-term follow-up in adults. Methods. All consecutive adul
Autor:
R.J. Snijder, Jurriën M. ten Berg, Martijn C. Post, Laura E. Renes, Martin J. Swaans, Maarten J. Suttorp
Publikováno v:
Journal of Interventional Cardiology, Vol 2020 (2020)
Journal of Interventional Cardiology
Journal of Interventional Cardiology
Objective. To study the safety and efficacy of microtransesophageal echocardiography (micro-TEE) and TEE during percutaneous atrial septal defect (ASD) and patent foramen ovale (PFO) closure. Background. TEE has proven to be safe during ASD and PFO c